Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 250
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01276210 | Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases | ||
| NCT00602147 | Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan | ||
| NCT05156060 | Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer | ||
| NCT06922825 | Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients | ||
| NCT00949052 | Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer | ||
| NCT01928160 | Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT04013880 | ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT00425750 | Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | ||
| NCT04883827 | Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer | ||
| NCT04310345 | Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents | ||
| NCT00898664 | DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer | ||
| NCT03925350 | Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation | ||
| NCT00573404 | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors | ||
| NCT01207895 | Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer | ||
| NCT06828588 | Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy | ||
| NCT00837876 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | ||
| NCT04327999 | Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System | ||
| NCT00930930 | Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer | ||
| NCT00898027 | Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer | ||
| NCT03932786 | Studying Health Outcomes After Treatment in Patients With Retinoblastoma | ||
| NCT04461171 | Enhanced Recovery After Surgery in Extremity Sarcoma | ||
| NCT01096407 | Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel | ||
| NCT00897117 | Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer | ||
| NCT00503997 | Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT00082667 | Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast | ||
| NCT05764395 | Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors | ||
| NCT06482957 | Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | ||
| NCT05747625 | (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma | ||
| NCT01951664 | Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors | ||
| NCT01031446 | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer | ||
| NCT00898209 | Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE) | ||
| NCT00892801 | Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer | ||
| NCT00544648 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | ||
| NCT06819228 | Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer | ||
| NCT00898430 | Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy | ||
| NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | ||
| NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | ||
| NCT06638398 | Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules | ||
| NCT05108805 | Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting | ||
| NCT02702310 | Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides | ||
| NCT03054038 | Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer | ||
| NCT00896662 | Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | ||
| NCT00469898 | Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT01007422 | Opioids Titration in Hospice Patients | ||
| NCT02923037 | Hatha Yoga in Breast Cancer Survivors | ||
| NCT00469937 | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases | ||
| NCT05770531 | Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy | ||
| NCT00550537 | Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT00483639 | Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer |
